DDX56 and colorectal cancer: One such TCGA screen of candidate genes in colorectal cancer identified that loss of DDX56 reduced intron retention and tumor suppressor WEE1 expression, which functions as a G2-M DNA damage checkpoint, postulating that DDX56 could serve as a potential prognostic biomarker of colorectal cancer [85].